CN104490989A - Traditional Chinese medicine composition for treating nasosinusitis - Google Patents
Traditional Chinese medicine composition for treating nasosinusitis Download PDFInfo
- Publication number
- CN104490989A CN104490989A CN201410708511.9A CN201410708511A CN104490989A CN 104490989 A CN104490989 A CN 104490989A CN 201410708511 A CN201410708511 A CN 201410708511A CN 104490989 A CN104490989 A CN 104490989A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- medicine composition
- traditional chinese
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/237—Notopterygium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/238—Saposhnikovia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/26—Aristolochiaceae (Birthwort family), e.g. heartleaf
- A61K36/268—Asarum (wild ginger)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine composition for treating nasosinusitis. The traditional Chinese medicine composition is prepared from the following components in parts by weight: 25-35 parts of ligusticum wallichii, 10-20 parts of divaricate saposhnikovia root, 10-20 parts of asarum, 10-20 parts of notopterygium, 10-20 parts of sinapis alba and 5-15 parts of liquorice. The Chinese medicinal herbs such as ligusticum wallichii, divaricate saposhnikovia root, asarum, notopterygium, sinapis alba and liquorice, with the efficacies of promoting the circulation of qi, dispelling wind and relieving pain are adopted to work together, so as to effectively treat the nasosinusitis. The traditional Chinese medicine composition is fast in acting, thorough to cure once and for all, and free of recurrence and the like; and the raw medicinal materials are natural plants, so that the traditional Chinese medicine composition is free of a toxic or side effect, reasonable in formula and low in cost.
Description
Technical field
The present invention relates to a kind of Chinese medicine, be specifically related to a kind of Chinese medicine composition for the treatment of sinusitis.
Background technology
Sinusitis is maxillary sinus, the general designation of sieving the mucosa irritation of hole, sinus frontalis and sphenoid sinus, is nose section common disease.It is the nonspecific inflammation of sinus mucosa, is a kind of nose section common frdquently encountered disease, can be divided into acute and chronic two classes, wherein in the majority with chronic person.Very harmful to health of sinusitis, it can cause headache, dizziness, insomnia forgetfulness, upset, absent minded etc., it also can become focus, affects surrounding tissue inflammation, also can cause the complication of harm people life security if be in a bad way.In recent years, day by day serious along with the advancing by leaps and bounds of science and technology, urbanization of villages, atmospheric pollution.Harmful, noxious substance, anaphylaxis material that per nasal sucks increase, and make the obvious ascendant trend of the sickness rate of sinusitis.The brain worker of young white collar, owing to lacking motion and working environment ventilates smooth, immunologic hypofunction, to various harmful gas and allergin toleration poor, become the group of people at high risk of this disease.
At present, the medicine for the treatment of sinusitis mainly contains Western medicine and Chinese medicine.Generally take whole body application antibiotic and sulfonamides to treat for acute sinusitis clinically, the vasoconstrictor of intranasal instillation simultaneously; For chronic sinusitis take intranasal to drip ventilation and the drain of pus tears that vasoconstrictor is beneficial to nasal sinuses, the serious feasible operation on nasal sinus therapy of chronic sinusitis being difficult to cure; Though application antibiotic therapy sinusitis can get effect for the moment, one meets flu will have a relapse, and then patient suffering is greatly and costly to adopt operative therapy.The kind of Chinese medicine is many, and mostly adopting with Fructus Xanthii is monarch drug composition, though toxic and side effects is little, onset is slow, curative effect is unsatisfactory.
Summary of the invention
For the deficiencies in the prior art, the object of this invention is to provide a kind of natural formula, have no side effect, thoroughly effect a radical cure, the Chinese medicine composition of not treatment sinusitis repeatedly.
In order to achieve the above object, the technical scheme that the present invention takes is:
Treat a Chinese medicine composition for sinusitis, by weight and component be: Rhizoma Chuanxiong 25 ~ 35 parts, Radix Saposhnikoviae 10 ~ 20 parts, Herba Asari 10 ~ 20 parts, Rhizoma Et Radix Notopterygii 10 ~ 20 parts, Semen Sinapis Albae 10 ~ 20 parts, 5 ~ 15 parts, Radix Glycyrrhizae.
As preferred component, by weight and component be: Rhizoma Chuanxiong 27 ~ 33 parts, Radix Saposhnikoviae 12 ~ 18 parts, Herba Asari 12 ~ 18 parts, Rhizoma Et Radix Notopterygii 12 ~ 18 parts, Semen Sinapis Albae 12 ~ 18 parts, 7 ~ 13 parts, Radix Glycyrrhizae.
As preferred component, by weight and component be: Rhizoma Chuanxiong 29 ~ 31 parts, Radix Saposhnikoviae 14 ~ 16 parts, Herba Asari 14 ~ 16 parts, Rhizoma Et Radix Notopterygii 14 ~ 16 parts, Semen Sinapis Albae 14 ~ 16 parts, 9 ~ 11 parts, Radix Glycyrrhizae.
As better composition, by weight and component be: Rhizoma Chuanxiong 30 parts, Radix Saposhnikoviae 15 parts, Herba Asari 15 parts, Rhizoma Et Radix Notopterygii 15 parts, Semen Sinapis Albae 15 parts, 10 parts, Radix Glycyrrhizae.
The instructions of taking of medicine of the present invention: cleaned by crude drug and be ground into powder, add and be decocted in water for oral dose, also can make the oral medicines such as tablet, granule, oral liquid, capsule by powder sterilization further.
Crude drug of the present invention has following pharmacology:
Rhizoma Chuanxiong, nature and flavor are pungent, warm, have effect of activating blood circulation and dissipating phlegm, activating QI to alleviate the depression, wind-expelling pain-stopping, and in this formula, Rhizoma Chuanxiong is kind controls few sun, JUE YIN meridian headache; Radix Saposhnikoviae, nature and flavor are pungent, sweet, tepor, have effect of expelling pathogenic wind from the body surface, removing dampness to relieve pain, antipruritic, the clear sharp head of spasmolytic; Herba Asari, property is pungent, warm, mild toxicity, has that cold expelling dispels the wind, warming the lungization is soft, effect that a surname opens up key, and is longer than and is in harmony shaoyin channel headache; Rhizoma Et Radix Notopterygii, nature and flavor are pungent, bitter, warm in nature, have effect of loose exterior cold, wind-damp dispelling, sharp joint, pain relieving; Semen Sinapis Albae, nature and flavor are pungent, warm, have the effect of reducing phlegm by drink, mass dissipating and swelling eliminating; Radix Glycyrrhizae, property is sweet, flat, has effect of QI invigorating invigorating middle warmer, relieving spasm to stop pain, nourishing the lung to arrest cough, eliminating fire and detoxication, coordinating the actions of various ingredients in a prescription.
Compared with prior art, the beneficial effect that the present invention has: adopt and there are activating QI to alleviate the depression, the Rhizoma Chuanxiong of wind-expelling pain-stopping effect and Radix Saposhnikoviae, Herba Asari, Rhizoma Et Radix Notopterygii, Semen Sinapis Albae, these Chinese medicinal herbses of Radix Glycyrrhizae interact, effective treatment sinusitis, has rapid-action, thorough radical cure, the not feature such as repeatedly; Crude drug is all natural plants, has no side effect, and formula is reasonable and cost is low.
Be described further below in conjunction with the beneficial effect of clinical trial to this medicine:
Patient data: patient 36 example, man 21 example, female 15 example; 5 ~ 48 years old age, course of disease recurrent exerbation 1 ~ 6 year; X line is all adopted to take the photograph sheet or CT scan is clarified a diagnosis.
Symptoms: 1. have a stuffy nose: not etc., how because of caused by the congested swelling of nasal mucosa and secretions increase, nasal obstruction often can not cause temporary olfactory disorder to weight; 2. pus tears are many: nasal mucus mostly is purulence or glutinous purulence, blow clean, can with a little blood in pus tears, anaerobe or coli-infection person's pus tears stench, pus tears can after flow to pharyngeal and throat, stimulate local mucosa to cause to itch, feel sick, cough and expectoration; 3. have a headache: chronic purulent nasosinustis is generally obvious local pain or headache; 4. other: because pus tears person who lives in exile is pharyngeal and long-term mouth breathing, often with chronic pharyngitis symptom, as abundant expectoration, foreign body sensation or have sore throat, if affect pharyngotympanic tube, also can have the symptom such as tinnitus, deafness.
Efficacy determination: recovery from illness, the common sympton such as nasal obstruction, pus tears, headache and sign disappear, and do not recur for more than 3 months; Effective: during outbreak, the symptoms such as common sympton such as nasal obstruction, pus tears, headache and sign obviously alleviate than before.Invalid: treat more than 3 courses for the treatment of, the state of an illness is substantially unchanged or increase the weight of.
Efficacy result: recovery from illness 20 example, accounts for 56%; Effective 14 examples, account for 41%; Invalid 1 example, accounts for 3%; Total effective rate is 97%.
Detailed description of the invention
Below in conjunction with specific embodiment, the present invention is further described.
Embodiment 1
Treat a Chinese medicine composition for sinusitis, its component is by weight: Rhizoma Chuanxiong 35 parts, Radix Saposhnikoviae 20 parts, Herba Asari 20 parts, Rhizoma Et Radix Notopterygii 10 parts, Semen Sinapis Albae 10 parts, 5 parts, Radix Glycyrrhizae.Crude drug is cleaned and is ground into powder, add and be decocted in water for oral dose.
Embodiment 2
Treat a Chinese medicine composition for sinusitis, its component is by weight: Rhizoma Chuanxiong 33 parts, Radix Saposhnikoviae 18 parts, Herba Asari 18 parts, Rhizoma Et Radix Notopterygii 12 parts, Semen Sinapis Albae 12 parts, 7 parts, Radix Glycyrrhizae.Cleaned by crude drug and be ground into powder, tablet oral medicine is made in sterilization further.
Embodiment 3
Treat a Chinese medicine composition for sinusitis, its component is by weight: Rhizoma Chuanxiong 30 parts, Radix Saposhnikoviae 15 parts, Herba Asari 15 parts, Rhizoma Et Radix Notopterygii 15 parts, Semen Sinapis Albae 15 parts, 10 parts, Radix Glycyrrhizae.Cleaned by crude drug and be ground into powder, particulate oral medicine is made in sterilization further.
Embodiment 4
Treat a Chinese medicine composition for sinusitis, its component is by weight: Rhizoma Chuanxiong 27 parts, Radix Saposhnikoviae 12 parts, Herba Asari 12 parts, Rhizoma Et Radix Notopterygii 18 parts, Semen Sinapis Albae 18 parts, 13 parts, Radix Glycyrrhizae.Cleaned by crude drug and be ground into powder, sterilization makes oral liquid further.
Embodiment 5
Treat a Chinese medicine composition for sinusitis, its component is by weight: Rhizoma Chuanxiong 25 parts, Radix Saposhnikoviae 10 parts, Herba Asari 10 parts, Rhizoma Et Radix Notopterygii 20 parts, Semen Sinapis Albae 20 parts, 15 parts, Radix Glycyrrhizae.Cleaned by crude drug and be ground into powder, capsule oral medicine is made in sterilization further.
It should be pointed out that above case is only the representational example of the present invention.Obviously, technical scheme of the present invention is not limited to above-described embodiment, can also have many degeneration.
Claims (4)
1. treat a Chinese medicine composition for sinusitis, it is characterized in that, by weight and component be: Rhizoma Chuanxiong 25 ~ 35 parts, Radix Saposhnikoviae 10 ~ 20 parts, Herba Asari 10 ~ 20 parts, Rhizoma Et Radix Notopterygii 10 ~ 20 parts, Semen Sinapis Albae 10 ~ 20 parts, 5 ~ 15 parts, Radix Glycyrrhizae.
2. a kind of Chinese medicine composition for the treatment of sinusitis according to claim 1, is characterized in that, by weight and component be: Rhizoma Chuanxiong 27 ~ 33 parts, Radix Saposhnikoviae 12 ~ 18 parts, Herba Asari 12 ~ 18 parts, Rhizoma Et Radix Notopterygii 12 ~ 18 parts, Semen Sinapis Albae 12 ~ 18 parts, 7 ~ 13 parts, Radix Glycyrrhizae.
3. a kind of Chinese medicine composition for the treatment of sinusitis according to claim 2, is characterized in that, by weight and component be: Rhizoma Chuanxiong 29 ~ 31 parts, Radix Saposhnikoviae 14 ~ 16 parts, Herba Asari 14 ~ 16 parts, Rhizoma Et Radix Notopterygii 14 ~ 16 parts, Semen Sinapis Albae 14 ~ 16 parts, 9 ~ 11 parts, Radix Glycyrrhizae.
4. a kind of Chinese medicine composition for the treatment of sinusitis according to claim 3, is characterized in that, by weight and component be: Rhizoma Chuanxiong 30 parts, Radix Saposhnikoviae 15 parts, Herba Asari 15 parts, Rhizoma Et Radix Notopterygii 15 parts, Semen Sinapis Albae 15 parts, 10 parts, Radix Glycyrrhizae.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410708511.9A CN104490989A (en) | 2014-11-27 | 2014-11-27 | Traditional Chinese medicine composition for treating nasosinusitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410708511.9A CN104490989A (en) | 2014-11-27 | 2014-11-27 | Traditional Chinese medicine composition for treating nasosinusitis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104490989A true CN104490989A (en) | 2015-04-08 |
Family
ID=52932503
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410708511.9A Pending CN104490989A (en) | 2014-11-27 | 2014-11-27 | Traditional Chinese medicine composition for treating nasosinusitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104490989A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2000212094A (en) * | 1998-11-18 | 2000-08-02 | Takeda Chem Ind Ltd | Pharmaceutical preparation for oral cavity |
| CN1524542A (en) * | 2003-02-24 | 2004-09-01 | 黄文珍 | Medicament for treating acute and chronic rhinitis and nasosinusitis |
-
2014
- 2014-11-27 CN CN201410708511.9A patent/CN104490989A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2000212094A (en) * | 1998-11-18 | 2000-08-02 | Takeda Chem Ind Ltd | Pharmaceutical preparation for oral cavity |
| CN1524542A (en) * | 2003-02-24 | 2004-09-01 | 黄文珍 | Medicament for treating acute and chronic rhinitis and nasosinusitis |
Non-Patent Citations (3)
| Title |
|---|
| 张秋雨: "《方剂学》", 31 August 2005, 第四军医大学出版社 * |
| 郭长青等: "《耳穴》", 28 February 2010, 西安交通大学出版社 * |
| 陈柏林: "川芎茶调散加减治疗副鼻窦炎16例", 《中国社区医师》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102512502B (en) | Traditional Chinese medicinal composition for treating rhinitis | |
| CN1480189A (en) | Medication for treating rhinitis | |
| CN103110706B (en) | Traditional Chinese medicine composition for treating rhinitis and preparation method thereof | |
| CN102614306A (en) | Traditional Chinese herbal preparation for treating chronic nasosinusitis | |
| CN104116830A (en) | Medicinal liquor for treating pulmonary abscess and preparation method thereof | |
| CN105012585A (en) | Traditional Chinese medicine for treating rhinitis | |
| CN104800714A (en) | Traditional Chinese medicine composition for treating chronic pharyngitis | |
| CN103623267A (en) | Medication for treating allergic rhinitis | |
| CN101703701B (en) | Medicament for treating facioplegia | |
| CN103933502A (en) | Traditional Chinese medicine liquid preparation for treating rhinitis and preparation method thereof | |
| CN110179925A (en) | A kind of Chinese medicine composition and preparation method thereof for treating respiratory disease | |
| CN103690812A (en) | Traditional Chinese medicine composition for curing chronic pharyngitis | |
| CN105477484A (en) | Medicine for treating allergic asthma | |
| CN1060081C (en) | Pure Chinese medicinal syrup preparation and its production tech. | |
| CN104490989A (en) | Traditional Chinese medicine composition for treating nasosinusitis | |
| CN104958726A (en) | Traditional Chinese medicine composition for treating rhinitis | |
| CN105833034A (en) | Traditional Chinese medicine composition | |
| CN104857075A (en) | Traditional Chinese medicinal composition for treating rhinitis, nasal polyp and sphagitis, and preparation method thereof | |
| CN101129543A (en) | Chinese ephedra Huagai powder | |
| CN103948777A (en) | Traditional Chinese medicine for treating sinusitis | |
| CN105168718A (en) | Application of traditional Chinese medicine composition in preparation of drugs for treating rhinitis, nasosinusitis and paranasal sinusitis | |
| CN105998608A (en) | Traditional Chinese medicine composition for treating rhinitis | |
| CN105362548A (en) | Traditional Chinese medicine for treating allergic asthma | |
| CN105663514A (en) | Traditional Chinese medicine composition for treating chronic rhinitis | |
| CN104117038A (en) | Traditional Chinese medicine wine for treating influenza and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150408 |
|
| WD01 | Invention patent application deemed withdrawn after publication |